15th World Clinical Biomarkers and CDx Summit | September 22-25, 2025 | Boston, MA
September 22 - 25, 2025 - MA USHanson Wade
info@hansonwade.com
Phone:+1 617 455 4188
Driven by advancements in genomic profiling, omics, and AI technologies, the biomarkers and diagnostics field continues to surge, with Roche and AstraZeneca's world-first digital pathology CDx approval in April taking the number of approved CDx tests to a record high of 188. We are now witnessing a need for new, stronger co-development partnerships to validate novel biomarkers, navigate global in vitro diagnostic regulation, and harmonize commercialization; which will in turn accelerate adoption of these drug-diagnostics across diverse therapeutic areas and markets. Returning for its 15th anniversary this September, the World Clinical Biomarkers and Companion Diagnostics Summit will unite 600+ industry leaders across biopharma, CDx developers, testing labs, regulators, and payers to advance clinical biomarker strategies and accelerate drug-diagnostics to market for improved patient diagnosis, stratification, and monitoring. Join us in celebrating 15 years of progress and be a part of the conversations and collaborations to define the next 15. Time: 8:00 AM - 6:00 PM